Leadership & Pay ·
Imunon, Inc. announced the retirement of interim Chief Financial Officer Jeffrey Church, effective July 1, 2026, and…
IMNNImunon, Inc.
Imunon, Inc. announced the retirement of interim Chief Financial Officer Jeffrey Church, effective July 1, 2026, and the appointment of Josh Blacher to serve as the new interim Chief Financial Officer under a master services agreement with Danforth Health, Inc. Mr. Church will continue in a consulting role with a $10,000 monthly retainer. Imunon, Inc. is a life sciences company focused on developing therapeutic solutions.